Quantbot Technologies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quantbot Technologies’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	+8,633	New	+$1.17M	0.05%	502
2026 Q1	–	Sell	-33,000	Closed	-$4.02M	–	2214
2025 Q4	$4.02M	Buy	+33,000	New	+$3.78M	0.13%	234
2025 Q3	–	Sell	-47,650	Closed	-$3.95M	–	2161
2025 Q2	$3.95M	Buy	47,650 +4,311	+10%	+$344K	0.1%	280
2025 Q1	$3.51M	Sell	43,339 -4,955	-10%	-$443K	0.11%	262
2024 Q4	$4.35M	Buy	48,294 +11,663	+32%	+$1.13M	0.16%	188
2024 Q3	$3.62M	Buy	+36,631	New	+$3.6M	0.14%	213
2024 Q2	–	Sell	-23,570	Closed	-$2.24M	–	1968
2024 Q1	$2.24M	Buy	+23,570	New	+$2.19M	0.13%	244
2023 Q4	–	Sell	-37,000	Closed	-$2.7M	–	2048
2023 Q3	$2.7M	Buy	37,000 +7,939	+27%	+$634K	0.18%	151
2023 Q2	$2.42M	Buy	29,061 +9,151	+46%	+$765K	0.16%	184
2023 Q1	$1.52M	Buy	+19,910	New	+$1.65M	0.11%	279
2022 Q4	–	Sell	-7,119	Closed	-$564K	–	2169
2022 Q3	$564K	Buy	7,119 +5,686	+397%	+$479K	0.04%	540
2022 Q2	$106K	Sell	1,433 -14,412	-91%	-$1.08M	0.01%	1129
2022 Q1	$1.42M	Sell	15,845 -2,747	-15%	-$254K	0.12%	246
2021 Q4	$2.08M	Buy	+18,592	New	+$2.24M	0.17%	172
2021 Q3	–	Sell	-22,485	Closed	-$3.04M	–	1964
2021 Q2	$3.04M	Buy	+22,485	New	+$2.96M	0.24%	101
2021 Q1	–	Sell	-21,800	Closed	-$3.07M	–	1807
2020 Q4	$3.07M	Buy	21,800 +7,590	+53%	+$972K	0.32%	86
2020 Q3	$1.58M	Buy	14,210 +8,031	+130%	+$900K	0.18%	160
2020 Q2	$691K	Sell	6,179 -3,169	-34%	-$312K	0.09%	213
2020 Q1	$723K	Buy	+9,348	New	+$828K	0.47%	55

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Quantbot Technologies's XBI Position: Q2 2026 in Review

Quantbot Technologies opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 8,633 shares worth $1.37M. The stake represents 0.05% of the portfolio and ranks #502 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in XBI as recently as Q4 2025.

Quantbot Technologies first reported a position in XBI in Q1 2020 and has held it in 19 quarters since. The position peaked at $4.35M in Q4 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Quantbot Technologies held 8,633 shares of State Street SPDR S&P Biotech ETF worth $1.37M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Quantbot Technologies position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.05% of Quantbot Technologies's portfolio in Q2 2026, its #502 holding.
Quantbot Technologies first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 19 quarters since.
Quantbot Technologies's State Street SPDR S&P Biotech ETF position peaked at $4.35M in Q4 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.